Twitter | Search | |
Maryam Lustberg
Breast Cancer Oncologist and Researcher
90
Tweets
350
Following
184
Followers
Tweets
Maryam Lustberg retweeted
Doreen Agnese Dec 11
Episode 22: The Spielman High-Risk Breast Cancer Clinic with Doreen Agnese by The James Cancer-Free World Podcast on SoundCloud - Hear the world’s sounds
Reply Retweet Like
Maryam Lustberg retweeted
Victoria K Dec 11
Help reform in Ohio! Our doctors should be making our medical decisions of the best treatment for our condition, not AI or someone behind a desk who has probably never been to Med school.
Reply Retweet Like
Maryam Lustberg Dec 10
thanks for all that you do to raise awareness
Reply Retweet Like
Maryam Lustberg Dec 8
Progress and much work to be done Long-Term Survivorship Care After Cancer Treatment - Summary of a 2017 National Cancer Policy Forum Workshop | JNCI: Journal of the National Cancer Institute | Oxford Academic
Reply Retweet Like
Maryam Lustberg retweeted
Mina S. Sedrak Dec 7
CARG BC Risk Score! A new tool to predict toxicity to neo/adj chemo for older adults with breast cancer
Reply Retweet Like
Maryam Lustberg retweeted
Tatiana Prowell, MD Dec 7
Dr. Ann Partridge update on status of POSITIVE, prospective study in which 500 premeno women <42 yrs (after 18-30 mos of endocrine tx) interrupt ET to conceive: expect accrual complete in ~1.5 yrs
Reply Retweet Like
Maryam Lustberg Dec 6
Replying to @Canon1953
In ER pos breast cancers, longer treatment with aromatase inhibitors (AI) to 10 years caused more toxicity and no benefit in disease recurrence. Data will continue to mature but for stage 1 node negative breast cancer, continuing to 10 years after 5 years of AI is low/no benefit
Reply Retweet Like
Maryam Lustberg Dec 6
Staggering morbidity of cancer treatment on financial health for AYAs. Need greater awareness and better strategies during and after treatment to reduce cancer toxicity burden.
Reply Retweet Like
Maryam Lustberg Dec 6
Agreed! More is not always more.
Reply Retweet Like
Maryam Lustberg Dec 5
Helpful summary of strategies in optimizing therapy in early breast cancer from Dr Joseph Sprano
Reply Retweet Like
Maryam Lustberg retweeted
MASCC/ISOO 2019 Nov 28
Toxicities of anti-cancer treatments: Advance the discussion. Submit your research now
Reply Retweet Like
Maryam Lustberg Dec 5
Great time meeting OSU UH and CCF collaborators
Reply Retweet Like
Maryam Lustberg Dec 5
Changing landscape of metastatic her2 posistve Breast cancer succinctly captured by Eric Winer
Reply Retweet Like
Maryam Lustberg Dec 5
KATHERINE study - exciting to have more options to improve outcomes in Her2 positive disease with residual disease after standard preop chemo
Reply Retweet Like
Maryam Lustberg retweeted
Rebecca Olin MD Nov 30
Matthew Drake: if you use Denosumab and want to stop, need to chase it with bisphosphonate to avoid rapid bone loss. Yikes!
Reply Retweet Like
Maryam Lustberg Nov 28
Parallel session on June 21, 2019 sponsored by neurological complications study group on novel strategies for CIPN and treatment associated cognitive problems during and after cancer therapy.
Reply Retweet Like
Maryam Lustberg Nov 27
Reply Retweet Like
Maryam Lustberg retweeted
NCCN Meetings Aug 8
One week away! Register @ for the Acute Congress, hosted by ! August 15 in Columbus, OH.
Reply Retweet Like
Maryam Lustberg Nov 26
Reply Retweet Like
Maryam Lustberg retweeted
Dr Hannah Rose Wardill Nov 20
abstract submission is just around the corner! What will you be bringing to next year's meeting?
Reply Retweet Like